Trial intelligence / Profile preview

Liu-Wei-Die-Huang-Wan for Osteoarthritis

NCT04108832Phase 2Completed

Sponsor
Chung Shan Medical University
Start
Jan 2012
Primary completion
Oct 2013
Modality
Herbal formula
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of liu wei di huang wan in osteoarthritis (OA) (2 arms), sponsored by Chung Shan Medical University. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 4 weeks. Started Jan 2012; status: completed.

02

Drugs

liu wei di huang wan
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04108832.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04108832.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call